Commentary by Judith Brenner MD, Associate Program Director, NYU Internal Medicine Residency Program
This week’s Annals of Internal Medicine focused on angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB). Two studies …
Commentary by David Steckman MD, PGY-2 and William Slater MD, Associate Professor of Medicine, Division of Cardiology
Case: A 42 year-old man presents to clinic for routine follow-up. He is found to …
Welcome to the first post of our newest series. In this series, we’ll try to cut through some of the media hype and summarize the health care proposals put forward by …
Is there evidence to support the use of Lantus® (human insulin analog glargine) administered Q12h in Type 1 Diabetes?
Commentary by Kathy Lee, Pharmacy ResidentÂ
The goal of diabetes management is to reduce …
Commentary by Rosemary Adamson MD, PGY-2
Medical error, the most formidable of topics, was under discussion at ground rounds this past week. Dr. Tom Delbanco visited us from Boston to show his movie …
Commentary by Michael Poles MD, Associate Editor, Clinical CorrelationsÂ
Another week, another set of shortcuts, so let’s take a quick look around the world of medical happenings. A quick trip into the …
Commentary by Mary Vouyiouklis MD, Fellow, and Ann Danoff MD, Director, Division of Endocrinology, Diabetes and Metabolism, NYU Medical Center
Welcome to our final case of our special diabetes series intended to highlight …
Commentary by Puja Korabathina PGY-3
This week’s medicine Grand Rounds was presented by Drs. Steven Woloshin and Lisa Schwartz , both alumni of NYU’s residency program who are currently performing research and practicing medicine …